Bottom line
FHLC vs MEDX: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 48% by weight.
But FHLC is far broader, holding 337 positions to 33 for MEDX, so beyond the top names it adds exposure MEDX doesn't have.
FHLC is cheaper at 0.084% vs 0.85% — a difference of $77 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +5.8% for MEDX (reporting dates differ).
Updated Nov 19, 2026
FHLC vs MEDX side by side
| FHLC | MEDX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Fidelity | Roundhill |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.85% |
| Annual cost per $10k | $8.4 | $85 |
| 10-yr cost on $10k (prospectus) | $108 | $1,049 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.6% | +28.4% |
| 5-yr return (annualized) | +7.2% | +5.8% |
| 10-yr return (annualized) | +8.8% | +5.7% |
| Best quarter | +16.4% | +15.0% |
| Worst quarter | −13.1% | −12.9% |
| Net assets (fund) | $3.3B | $19.1M |
| Number of holdings | 337 | 33 |
| Portfolio turnover | 3% | % |
| Returns as of | Nov 30, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | MEDX | Difference |
|---|---|---|---|
| 2024 | +2.6% | −4.7% | +7.3% |
| 2023 | +2.5% | −6.0% | +8.5% |
| 2022 | −5.5% | +4.2% | −9.7% |
| 2021 | +20.4% | +10.6% | +9.8% |
| 2020 | +18.1% | +9.0% | +9.1% |
| 2019 | +21.9% | +16.0% | +5.9% |
| 2018 | +5.5% | +1.7% | +3.9% |
| 2017 | +23.3% | +10.7% | +12.6% |
| 2016 | −3.3% | −8.0% | +4.7% |
Source: Fund prospectus bar charts
Holdings overlap
8 of FHLC's top 25 holdings also appear in MEDX's top 25.
| Holding | FHLC | MEDX |
|---|---|---|
| Eli Lilly & Co | 13.35% | 18.46% |
| Johnson & Johnson | 8.93% | 5.59% |
| AbbVie Inc | 6.42% | 8.85% |
| Merck & Co Inc | 4.66% | 3.96% |
| Amgen Inc | 3.00% | 3.91% |
| Pfizer Inc | 2.06% | 2.86% |
| Bristol-Myers Squibb Co | 1.93% | 4.42% |
| Regeneron Pharmaceuticals Inc | 1.15% | 2.06% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
FAQ
What is the difference between FHLC and MEDX?
Which is cheaper, FHLC or MEDX?
Should I own both FHLC and MEDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.